Pricing Log in Create free account

Jasper Therapeutics, Inc. (JSPR) vs Psyence Biomedical Ltd. (PBM)

Jasper Therapeutics, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Jasper Therapeutics, Inc. and Psyence Biomedical Ltd. are of similar size ($17.7M and $16.5M). Jasper Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 8 metrics below, Psyence Biomedical Ltd. leads on 5 and Jasper Therapeutics, Inc. on 3.

Valuation

Metric JSPR PBM Biotechnology median
P/E n/m 0.19 8.50
P/S n/m n/m 9.71
P/B 9.75 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.82 0.64
EV/Sales n/m n/m 9.21
Earnings yield (331.25%) 534.77% (33.15%)
Free cash flow yield (437.42%) (807.70%) (25.50%)

Profitability

Metric JSPR PBM Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (255.05%) (23.52%) (56.36%)
Return on assets (109.05%) (6.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric JSPR PBM Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 19.22% (138.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.48 8.09 4.72
Net debt to EBITDA 0.35 1.20 0.96

Dividend

Metric JSPR PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JSPR PBM Biotechnology median
Market cap 17.70m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack